文献速递膀胱癌与上尿路尿路上皮癌

根治性膀胱切除术的医院质量指标:疾病特异性并与死亡率结局相关

Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
PubMed 文献 · J Urol · 2019-08-08

研究利用美国国家癌症数据库2004至2014年1200家机构48341例根治性膀胱切除术数据,构建膀胱癌质量评分(BC-QS),该评分由医院切缘阳性率、淋巴结清扫率和新辅助化疗率组成,较高的BC-QS与较低的30天、90天和总死亡率相关。

要点

  • BC-QS由切缘阳性率、淋巴结清扫率和新辅助化疗率三项指标构成。
  • BC-QS较优的医院30天死亡调整OR 0.78(95%CI 0.64-0.96),90天死亡调整OR 0.84(95%CI 0.72-0.97)。
  • BC-QS较优的医院总死亡HR 0.86(95%CI 0.81-0.92)。

核心结论

  • BC-QS可反映根治性膀胱切除术的医院表现差异,较高的质量与较低的患者死亡率相关。
  • 作者认为该质量指标的验证为其被政策制定者和支付方用于衡量高成本手术医院质量提供了支持。

研究设计与样本

  • 使用美国国家癌症数据库识别2004至2014年施行根治性膀胱切除术的医院。
  • 构建混合效应模型评估7项质量指标的医院间差异,采用间接标准化对医院表现进行病例组合调整。
  • 共纳入1200家机构、48341例患者。

主要发现

  • 病例组合调整后,混合效应模型显示所有质量指标均存在显著的医院间差异。
  • BC-QS由医院切缘阳性率、淋巴结清扫率和新辅助化疗率组成。
  • BC-QS表现较好与较低的30天死亡率(调整OR 0.78,95%CI 0.64-0.96)和90天死亡率(OR 0.84,95%CI 0.72-0.97)相关。
  • BC-QS表现较好与较低的总死亡率相关(HR 0.86,95%CI 0.81-0.92)。
  • BC-QS较高的医院较BC-QS较低的医院手术量更高且更多隶属于学术机构(p <0.0001)。

关键数值与推荐

  • BC-QS由医院切缘阳性率、淋巴结清扫率和新辅助化疗率三项指标构成。
  • BC-QS较优与30天死亡率调整OR 0.78(95%CI 0.64-0.96)相关。
  • BC-QS较优与90天死亡率调整OR 0.84(95%CI 0.72-0.97)相关。
  • BC-QS较优与总死亡率HR 0.86(95%CI 0.81-0.92)相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Measuring quality is a high priority for health care systems globally. Despite the high perioperative morbidity, mortality, expenditures and performance variation of radical cystectomy there is a paucity of validated bladder cancer quality metrics. We aimed to create a hospital quality scoring system for radical cystectomy which is disease specific and associated with patient centered outcomes. MATERIALS AND METHODS: We used the National Cancer Database to identify hospitals where radical cystectomy was performed from 2004 to 2014. Mixed effects models were constructed to assess variation in hospital performance across 7 quality indicators. Indirect standardization was used to case mix adjust hospital performance. We assessed associations between quality indicators as well as the novel BC-QS (Bladder Cancer Quality Score) composite hospital quality metric with 30-day, 90-day and overall mortality using logistic and Cox regression, respectively. RESULTS: At 1,200 facilities radical cystectomy was performed in a total of 48,341 patients from 2004 to 2014. Mixed effects models demonstrated significant between hospital variation across all quality indicators after case mix adjustment. The composite BC-QS metric was composed of the hospital positive margin rate, the lymph node dissection rate and the neoadjuvant chemotherapy rate. Better BC-QS performance was associated with lower 30-day and 90-day mortality (adjusted OR 0.78, 95% CI 0.64-0.96, and OR 0.84, 95% CI 0.72-0.97, respectively) and overall mortality (HR 0.86, 95% CI 0.81-0.92). Hospitals with a higher BC-QS had higher volume and more were affiliated with an academic institution than hospitals with a lower BC-QS (p <0.0001). CONCLUSIONS: The BC-QS captures variations in the hospital performance of radical cystectomy and it shows an association of higher quality with lower patient mortality. Our validation of this quality metric provides support for its potential use by policy makers and payers in efforts to measure hospital quality for high cost surgeries.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Khanna A, Saarela O, Lawson K, et al. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes. J Urol. 2019. PMID: 31009290. doi:10.1097/JU.0000000000000282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。